Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.


Clinical Trial Description

This project will involve both retrospective and prospective data collection from participants enrolled in the LTOG cohort studies. We will perform long-term Chronic Lung Allograft Dysfunction (CLAD) phenotyping of lung transplant recipients who participated in the LTOG cohort studies utilizing data collected for routine clinical visits. Surviving lung transplant recipients who participated in the LTOG cohort studies will be recruited to enroll in the longitudinal portion of the project. The longitudinal component will include follow-up data collection at 6 month intervals while alive until study termination, study withdrawal, or no longer being seen for follow-up at the participating center. Follow-up data collection will include clinical data collected by study coordinators by reviewing medical records, functional assessment through administration of the Short Physical Performance Battery (SPPB), blood collection and surveys. Data from this project will be linked to data and samples collected during the LTOG cohort or ancillary studies. ;


Study Design


Related Conditions & MeSH terms

  • Lung Transplant Failure and Rejection

NCT number NCT04787822
Study type Observational
Source University of Pennsylvania
Contact
Status Enrolling by invitation
Phase
Start date June 15, 2021
Completion date May 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05050955 - AlloSure Lung Assessment and Metagenomics Outcomes Study
Terminated NCT04558333 - CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
Recruiting NCT05006742 - Comparison of Transbronchial Cryobiopsy and Forceps Biopsy in Lung Transplant Recipients N/A
Active, not recruiting NCT03656926 - Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) Phase 3
Recruiting NCT04837339 - Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation N/A
Terminated NCT04318587 - Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation N/A
Enrolling by invitation NCT05934617 - Trajectories of FEV1 After Lung Transplantation
Active, not recruiting NCT04126746 - Clinical Trials in Organ Transplantation Extension Study
Active, not recruiting NCT03657342 - Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Phase 3